Penumbra Inc.

NYSE: PEN · Real-Time Price · USD
295.75
3.93 (1.35%)
At close: May 02, 2025, 3:59 PM
296.00
0.08%
After-hours: May 02, 2025, 04:08 PM EDT
1.35%
Bid 288
Market Cap 11.45B
Revenue (ttm) 1.24B
Net Income (ttm) 42.23M
EPS (ttm) 1.08
PE Ratio (ttm) 273.84
Forward PE 59.17
Analyst Buy
Ask 299
Volume 312,570
Avg. Volume (20D) 513,203
Open 297.25
Previous Close 291.82
Day's Range 293.13 - 299.01
52-Week Range 148.00 - 310.00
Beta 0.56

About PEN

Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling...

Sector Healthcare
IPO Date Sep 18, 2015
Employees 4,500
Stock Exchange NYSE
Ticker Symbol PEN
Full Company Profile

Analyst Forecast

According to 16 analyst ratings, the average rating for PEN stock is "Buy." The 12-month stock price forecast is $318, which is an increase of 7.52% from the latest price.

Stock Forecasts

Earnings Surprise

Penumbra has released their quartely earnings on Apr 23, 2025:
  • Revenue of $324.14M exceeds estimates by $8.49M, with 16.32% YoY growth.
  • EPS of 0.83 exceeds estimates by 0.16, with 102.44% YoY growth.
  • 1 week ago
    +6.99%
    Penumbra shares are trading higher after the compa... Unlock content with Pro Subscription
    1 month ago
    +4.6%
    Penumbra shares are trading higher after B of A Securities initiated coverage on the stock with a Buy rating and announced a price target of $320.